iiinova — where your digital self keeps evolving

Harpal Dhillon @harpaldhillon.com · 25/09/2026

My experience across global health tells me we're thinking too small. We're trying too hard to improve the systems we've inherited, and not hard enough to transform them.

000

Harpal Dhillon @harpaldhillon.com · 24/09/2026

At some point, the appearance of collective action became a substitute for collective action itself

000

Harpal Dhillon @harpaldhillon.com · 24/09/2026

The internet killed humanity. AI is just the cherry on top.

000

Harpal Dhillon @harpaldhillon.com · 23/09/2026

When the person responsible for the mess looks at you to get them out of it.

000

Harpal Dhillon @harpaldhillon.com · 19/09/2026

Global health governance meeting reality

000

Harpal Dhillon @harpaldhillon.com · 04/09/2026

Cambridge will find itself facing difficult questions again about its governance

010

Harpal Dhillon @harpaldhillon.com · 02/09/2026

A timely piece from Margaret MacMillan on the changing international order and cooperation within it. It raises a question I keep coming back to. What happens to problems that depend on collective action when national and collective interests diverge? www.nytimes.com/2026/09/01/o...

nytimes.com

Opinion | A New World Order Is Coming. We Aren’t Ready.

We must be honest about the seriousness of the situation we’re in.

000

Harpal Dhillon @harpaldhillon.com · 02/09/2026

Keir Starmer enjoying the summer off while being paid and then resigning from politics is peak Keir!

010

Harpal Dhillon @harpaldhillon.com · 23/08/2026

If academia wants to draw a hard line around AI-assisted writing, it also has to be intellectually consistent about the human-assisted writing practices it has tolerated for decades.

000

Harpal Dhillon @harpaldhillon.com · 23/08/2026

There was a time I saw part of my PhD research presented as a poster, with someone else's name as first author. Plagiarism and intellectual theft are far more common in academia than academia likes to admit.

000

Harpal Dhillon @harpaldhillon.com · 21/08/2026

The more companies I advise, the less eccentric Rick Rubin seems to me.

000

Harpal Dhillon @harpaldhillon.com · 20/08/2026

The Guardian is part of the problem. Posting this comment on bluesky as they were acting all righteous leaving X

001

Harpal Dhillon @harpaldhillon.com · 20/08/2026

We’ve entered a post-industrial era of innovation with institutions still designed for the industrial one.

000

Harpal Dhillon @harpaldhillon.com · 20/08/2026

Funny how its always the people you think that would be supportive never end up being supportive...

000

Harpal Dhillon @harpaldhillon.com · 18/08/2026

It’s funny how often I interact with innovators who, when I mention preserving innovation react like "meh"

000

Harpal Dhillon @harpaldhillon.com · 16/08/2026

Religion was once a claim about what deserves devotion. The rich learned to turn it into a claim about what deserves obedience. Innovation was once a claim about what deserves investment. The rich have learned to turn it into a claim about what deserves escape.

000

Harpal Dhillon @harpaldhillon.com · 15/08/2026

Somewhere out there, a stranger still remembers the positive impact you had on their life.

000

Harpal Dhillon @harpaldhillon.com · 13/08/2026

Slowly, slowly then suddenly Climate change Antimicrobial resistance AI

000

Harpal Dhillon @harpaldhillon.com · 13/08/2026

Whatever got us into this mess shouldn’t automatically be the thing we trust to get us out of it.

000

Harpal Dhillon @harpaldhillon.com · 13/08/2026

It’s a real shame where we’re headed. At precisely the moment antimicrobial resistance demands greater cooperation, we’re retreating behind sovereignty. www.ft.com/content/5924...

ft.com

The west has given China the keys to the medicine cabinet

The US and Europe led the antibiotic era but then outsourced the means to sustain it

000

Harpal Dhillon @harpaldhillon.com · 13/08/2026

We've joined a cult of what's next, while losing sight of what must remain.

000

Harpal Dhillon @harpaldhillon.com · 03/08/2026

Quietly observing football's institutional fallout and if there are lessons for the custodian we need for AMR

000

Harpal Dhillon @harpaldhillon.com · 03/08/2026

I'm not a big film or cinema guy but I'm very glad I watched Odyssey

000

Harpal Dhillon @harpaldhillon.com · 02/08/2026

AI actually proves that skilled human judgment matters even more than before.

000

Harpal Dhillon @harpaldhillon.com · 24/07/2026

AMR deaths rose around 8% between 1990 and 2021, and are projected to rise another 70% by 2050. At what point do we stop asking how to do more of the same, and start asking whether we're solving the right problem?

010

Harpal Dhillon @harpaldhillon.com · 11/07/2026

You are definitely missing out!

010

Harpal Dhillon @harpaldhillon.com · 03/07/2026

So the next innovation may not be another programme or another funding mechanism. It may be assigning the preservation function our governance architecture still lacks. That may be the innovation that matters most.

000

Harpal Dhillon @harpaldhillon.com · 03/07/2026

But they also reveal something deeper: we keep asking finance to compensate for a governance function that remains unassigned. When governance is incomplete, finance compensates. When governance is well designed, finance catalyses. Institutional design is the multiplier.

120

Harpal Dhillon @harpaldhillon.com · 03/07/2026

Success upstream raises the cost of leaving preservation unowned downstream. The funds, incentives and partnerships built to support antimicrobial innovation have been essential.

110

Harpal Dhillon @harpaldhillon.com · 03/07/2026

The blueprint also points to AI as an area of future opportunity for diagnostics and discovery. Those advances matter, yet the faster AI delivers new therapies, the greater the need for an institution responsible for keeping them effective.

100

Harpal Dhillon @harpaldhillon.com · 03/07/2026

Who holds the enduring mandate to preserve antifungal effectiveness itself? Diagnostics, access, surveillance, stewardship and innovation are all essential. But none of them assigns any institution responsibility for keeping antifungals effective as resistance develops over time.

100

Harpal Dhillon @harpaldhillon.com · 24/06/2026

Ok I'll read Trump's Art of the Deal

110

Harpal Dhillon @harpaldhillon.com · 23/06/2026

It’s a shame that the 5th High-Level Ministerial on Antimicrobial Resistance has been postponed. I was hoping there would be clarity on who is actually responsible for preserving antibiotic effectiveness as a long-term strategic capability. Postponing the meeting postpones that question too.

110

Harpal Dhillon @harpaldhillon.com · 23/06/2026

I've created a table to summarise the results

000

Harpal Dhillon @harpaldhillon.com · 22/06/2026

The paper is best read downloaded rather than in the SSRN browser preview. Happy to receive critique, especially on where the framework may be under-specified or where particular governance dimensions may be doing too much work in the index.

000

Harpal Dhillon @harpaldhillon.com · 22/06/2026

Antibiotic effectiveness is a shared strategic capability, but its durability is determined by the weakest preservation architecture we are willing to tolerate.

100

Harpal Dhillon @harpaldhillon.com · 22/06/2026

🇺🇸 The United States scores Tier C, despite BARDA, CARB-X, and some of the world’s most advanced regulatory pathways. The regulatory and commercial structures that help a drug come into existence are not the same as those required to preserve its effectiveness.

100

Harpal Dhillon @harpaldhillon.com · 22/06/2026

Across 31 countries, ARGI shows that national capability does not reliably translate into custodianship. 🇹🇭 Thailand scores Tier B, the only low- or middle-income country in the sample to do so.

100

Harpal Dhillon @harpaldhillon.com · 22/06/2026

In a new working paper, I introduce the Antibiotic Reserve Governance Index (ARGI), which examines whether countries have the institutional architecture required to preserve antibiotic effectiveness over time. papers.ssrn.com/sol3/papers....

papers.ssrn.com

Measuring What Governs: The Antibiotic Reserve Governance Index (ARGI)

Antimicrobial resistance (AMR) is routinely framed as a microbiological inevitability, yet countries facing similar microbiological pressures often experience m

100

Harpal Dhillon @harpaldhillon.com · 19/06/2026

Neither have I and in my own experience it's not clever enough to do those things either (yet)

000

Harpal Dhillon @harpaldhillon.com · 19/06/2026

If AMR is as urgent as we say it is, are we convening to decide, or deciding to convene?

000

Harpal Dhillon @harpaldhillon.com · 18/06/2026

I find the psychological side of AMR fascinating. It is so hard to provide a new perspective to people working within it. Thats probably why I enjoy the challenge. Compared to other disease areas I actually get paid to operate in its definitely the hardest from a human perspective

000

Harpal Dhillon @harpaldhillon.com · 18/06/2026

I also use the sauna as a hobby and thats equally uncomfortable to do when exposed

000